Clinical trial

GOLD Stage I Chronic Obstructive Pulmonary Disease (COPD)

NCT01360788

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2009-02-01

PhaseN/A

Study timeline

Study start (unknown)2009-02-01Date precision: month

Registry last updated2011-05-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Mild Chronic Obstructive Pulmonary Diseaseunresolved

Respiratory Symptomsunresolved

Physical Activityunresolved

Interventions

Combination ipratropium/salbutamol or placebo (nebulization)DRUG

Sponsors & collaborators

Laval Universitylead sponsor

Boehringer Ingelheimcollaborator

Pfizercollaborator

Mapped research locations

QuébecQuebec, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01360788 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.